Transdermal Applications of Minimally Invasive Drug Delivery Systems: Current Trends and Future Perspectives
eBook 정보
This book presents detailed analyses of various minimally invasive drug delivery methods as well as the recent advances in devices such as microneedles, iontophoretic devices, probes, etc. This book will be of keen interest to a wide range of audiences, including clinical researchers working in the field of drug delivery and disease diagnosis, as well as undergraduate and postgraduate students from various disciplines such as pharmacy, pharmacology, pharmaceutics, biotechnology, and health sciences.
저자 정보
Prof. Malakapogu Ravindra Babu is currently serving as a Professor in Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India. Previously he served as a Professor and Research coordinator in Department of Pharmaceutics, School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India. Dr. Babu has a vast experience of more than 14 years in teaching and research. His key research area includes development of minimal invasive drug delivery systems such as Microneedles, Iontophoresis and transdermal patches.
Prof. Monica Gulati is the Registrar and Executive Dean at the School of Pharmaceutical Sciences, Lovely Professional University, India with more than 25 years of teaching, industry, research and administrative experience. Having completed her B. Pharm., M Pharm and PhD from UIPS, Panjab University, Chandigarh, Dr. Gulati served for two years in the R&D department of Panacea Biotec. She has served for more than 19 years at LPU in various academic and administrative roles. Her research forte is enhancing bio-performance of drug molecules, phytochemicals and probiotics and novel dosage forms especially in the area of colon targeting.
Prof. Vandana B. Patravale is currently a Professor of Pharmaceutics at the Institute of Chemical Technology, Mumbai, India. She has more than 30 years of teaching and research experience. She has over 200 refereed publications with over 10000 citations, 30 granted patents, 20 patents in pipeline and 2 trademark registries. She has published 2 books and 35 chapters with international publishers. She is an independent director of a device manufacturing company and listed as top 2% of World scientists. Her areas of research include development of nanocarriers with major emphasis on infectious diseases, cancer and neurodegenerative disorders.
Prof. Hélder Santos is a Full Professor in Department of Biomedical Engineering at the University of Groningen, The Netherlands. He is also Research Director at the University of Helsinki, Faculty of Pharmacy. He is also the co-founder of the startups Capsamedix Oy and Medixmicro Oy, and Coordinator of MSCA-ITN P4 FIT network in tendon repair. Prof. Santos research interests include the development of nanoparticles/nanomedicines and biomaterials for biomedical applications, particularly cancer and heart diseases.
Dr Kamal Dua is an Associate Professor Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), has a research experience of over 12 years working in the field of drug delivery targeting inflammatory diseases. He is also a Node Leader of Drug Delivery Research in the Centre for Inflammation at Centenary Institute, where the targets identified from the research projects are pursued to develop novel formulations as the first step towards translation into clinics. Dr Dua researches in two complementary areas; drug delivery and immunology, specifically addressing how these disciplines can advance one another helping the community to live longer and healthier.
Prof. Sachin Kumar Singh is a Professor and HoD for Pharmaceutical analysis and Chemistry at School of Pharmaceutical Sciences, Lovely Professional University, India. He holds his Masters of Pharmacy in Pharmaceutical Analysis from J.S.S. College of Pharmacy, Ooty, Tamil Nadu, India and holds PhD degree in Pharmaceutical Sciences from Karpagam University, Coimbatore, India. He has completed one DST-SERB funded project on development of SNEDDS of Polypeptide-k for treatment of diabetes mellitus.
